Mill Creek Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,767
| Closed | -$549K | – | 275 |
|
|
2025
Q1 | $549K | Hold |
6,767
| – | – | 0.01% | 149 |
|
|
2024
Q4 | $609K | Sell |
6,767
-218
| -3% | -$19.6K | 0.01% | 150 |
|
|
2024
Q3 | $690K | Sell |
6,985
-2,732
| -28% | -$270K | 0.02% | 141 |
|
|
2024
Q2 | $901K | Buy |
9,717
+7,596
| +358% | +$704K | 0.02% | 122 |
|
|
2024
Q1 | $201K | Sell |
2,121
-643
| -23% | -$61K | 0.01% | 229 |
|
|
2023
Q4 | $247K | Hold |
2,764
| – | – | 0.01% | 210 |
|
|
2023
Q3 | $202K | Hold |
2,764
| – | – | 0.01% | 212 |
|
|
2023
Q2 | $230K | Hold |
2,764
| – | – | 0.01% | 216 |
|
|
2023
Q1 | $211K | Hold |
2,764
| – | – | 0.01% | 225 |
|
|
2022
Q4 | $229K | Buy |
+2,764
| New | +$229K | 0.01% | 202 |
|